Fig. 5: MHY-1685-primed hCSCs improve heart function while reducing adverse remodeling. | Experimental & Molecular Medicine

Fig. 5: MHY-1685-primed hCSCs improve heart function while reducing adverse remodeling.

From: Human cardiac stem cells rejuvenated by modulating autophagy with MHY-1685 enhance the therapeutic potential for cardiac repair

Fig. 5

a Representative images of the M-mode of four experimental groups at 1 and 4 weeks postintervention. b Left ventricular ejection fraction (EF), c Left fractional shortening (FS), d Left ventricular internal diastolic dimension (LVIDd), e Left ventricular internal systolic dimension (LVIDs), f Relative wall thickness (RWT), g Septal wall thickness (SWT), h Posterior wall thickness (PWT). n = 6. (*p < 0.05 vs. control, #p < 0.05 vs. senescent hCSC). Data are shown as the mean ± S.E.M.

Back to article page